Papillary cystadenoma of the epididymis and broad ligament: Morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma

American Journal of Surgical Pathology

Volumn 38, Issue 5, 2014, Pages 713-718

  Cox, Roni ^a   Vang, Russell ^a,b   Epstein, Jonathan I ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Dept of Gynecology and Obstetrics Weinberg Building ^*  (United States)

Author keywords

clear cell papillary renal cell carcinoma; epididymis; papillary cystadenoma

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BROAD LIGAMENT; CYSTADENOMA; EPIDIDYMIS; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MALE GENITAL TRACT TUMOR; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BROAD LIGAMENT; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CYSTADENOMA, PAPILLARY; EPIDIDYMIS; FEMALE; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84899063332     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000152     Document Type: Article

References (32)

1. Sherrick JC. Papillary cystadenoma of the epididymis. Cancer.1956;9:403-407.
2. Price EB Jr. Papillary cystadenoma of the epididymis. A clinicopathologicanalysis of 20 cases. Arch Pathol. 1971;91:456-470.
3. Gersell DJ, King TC. Papillary cystadenoma of the mesosalpinx invon Hippel-Lindau disease. Am J Surg Pathol. 1988;12:145-149. (Pubitemid 18052948)
4. Datta MW, Ulbright TM, Young RH. Renal cell carcinomametastatic to the testis and its adnexa: a report of five casesincluding three that accounted for the initial clinical presentation.Int J Surg Pathol. 2001;9:49-56. (Pubitemid 32295123)
5. Mehta GU, Shively SB, Glasker S, et al. Von Hippel-Lindau disease:epididymal cystadenoma targeted by metastatic events. Urology.2007;69:1209.e9. e12.
6. Aydin H, Young RH, Ronnett BM, et al. Clear cell papillarycystadenoma of the epididymis and mesosalpinx: immunohistochemicaldifferentiation from metastatic clear cell renal cellcarcinoma. Am J Surg Pathol. 2005;29:520-523. (Pubitemid 40411186)
7. Gilcrease MZ, Schmidt L, Zbar B, et al. Somatic von Hippel-Lindaumutation in clear cell papillary cystadenoma of the epididymis. HumPathol. 1995;26:1341-1346. (Pubitemid 26001596)
8. Shen T, Zhuang Z, Gersell DJ, et al. Allelic deletion of VHL genedetected in papillary tumors of the broad ligament, epididymis, andretroperitoneum in von Hippel-Lindau disease patients. Int J SurgPathol. 2000;8:207-212.
9. Leung SY, Chan AS, Wong MP, et al. Expression of vascularendothelial growth factor in von Hippel-Lindau syndrome-associatedpapillary cystadenoma of the epididymis. Hum Pathol. 1998;29:1322-1324. (Pubitemid 28525537)
10. Lawrie CH, Larrea E, Larrinaga G, et al. Targeted next generationsequencing and non-coding RNA expression analysis of clear cellpapillary renal cell carcinoma suggests distinct pathologicalmechanisms from other renal tumour subtypes. J Pathol. 2013.[Epub ahead of print].
11. Fisher KE, Yin-Goen Q, Alexis D, et al. Gene expression profilingof clear cell papillary renal cell carcinoma: Comparison with clearcell renal cell carcinoma and papillary renal cell carcinoma. ModPathol. 2013. [Epub ahead of print].
12. Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cellcarcinoma: molecular and immunohistochemical analysis withemphasis on the von Hippel-Lindau gene and hypoxia-induciblefactor pathway-related proteins. Mod Pathol. 2011;24:1207-1220.
13. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum ofepithelial neoplasms in end-stage renal disease: an experience from66 tumor-bearing kidneys with emphasis on histologic patternsdistinct from those in sporadic adult renal neoplasia. Am J SurgPathol. 2006;30:141-153. (Pubitemid 43740182)
14. Srigley JR, Delahunt B, Eble JN, et al. The International Society ofUrological Pathology (ISUP) Vancouver classification of renalneoplasia. Am J Surg Pathol. 2013;37:1469-1489.
15. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cellcarcinoma: a distinct histopathologic and molecular genetic entity.Am J Surg Pathol. 2008;32:1239-1245.
16. Williamson SR, Eble JN, Cheng L, et al. Clear cell papillary renalcell carcinoma: differential diagnosis and extended immunohistochemicalprofile. Mod Pathol. 2013;26:697-708.
17. Gaffey MJ, Mills SE, Boyd JC. Aggressive papillary tumor ofmiddle ear/temporal bone and adnexal papillary cystadenoma.Manifestations of von Hippel-Lindau disease. Am J Surg Pathol.1994;18:1254-1260. (Pubitemid 24362439)
18. Calder CJ, Gregory J. Papillary cystadenoma of the epididymis: areport of two cases with an immunohistochemical study. Histopathology.1993;23:89-91. (Pubitemid 23233259)
19. Torikata C. Papillary cystadenoma of the epididymis. An ultrastructuraland immunohistochemical study. J Submicrosc CytolPathol. 1994;26:387-393.
20. Ozcan A, Shen SS, Hamilton C, et al. PAX 8 expression in nonneoplastictissues, primary tumors, and metastatic tumors: a comprehensiveimmunohistochemical study. Mod Pathol. 2011;24:751-764.
21. Laury AR, Perets R, Piao H, et al. A comprehensive analysis ofPAX8 expression in human epithelial tumors. Am J Surg Pathol.2011;35:816-826.
22. Tong GX, Memeo L, Colarossi C, et al. PAX8 and PAX2immunostaining facilitates the diagnosis of primary epithelialneoplasms of the male genital tract. Am J Surg Pathol. 2011;35:1473-1483.
23. Sangoi AR, Karamchandani J, Kim J, et al. The use ofimmunohistochemistry in the diagnosis of metastatic clear cell renalcell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma,and CD10. Adv Anat Pathol. 2010;17:377-393.
24. Al-Ahmadie HA, Alden D, Qin LX, et al. Carbonic anhydrase IXexpression in clear cell renal cell carcinoma: an immunohistochemicalstudy comparing 2 antibodies. Am J Surg Pathol. 2008;32:377-382. (Pubitemid 351398928)
25. Gupta R, Balzer B, Picken M, et al. Diagnostic implications oftranscription factor pax 2 protein and transmembrane enzymecomplex carbonic anhydrase IX immunoreactivity in adult renalepithelial neoplasms. Am J Surg Pathol. 2009;33:241-247.
26. Genega EM, Ghebremichael M, Najarian R, et al. Carbonicanhydrase IX expression in renal neoplasms: correlation with tumortype and grade. Am J Clin Pathol. 2010;134:873-879.
27. Oosterwijk-Wakka JC, Boerman OC, Mulders PF, et al. Applicationof monoclonal antibody G250 recognizing carbonic anhydraseIX in renal cell carcinoma. Int J Mol Sci. 2013;14:11402-11423.
28. Ivanov S, Liao SY, Ivanova A, et al. Expression of hypoxiainduciblecell- surface transmembrane carbonic anhydrases in humancancer. Am J Pathol. 2001;158:905-919. (Pubitemid 32221783)
29. Potter CP, Harris AL. Diagnostic, prognostic and therapeuticimplications of carbonic anhydrases in cancer. Br J Cancer. 2003;89:2-7. (Pubitemid 36897927)
30. Nogales FF, Goyenaga P, Preda O, et al. An analysis of five clearcell papillary cystadenomas of mesosalpinx and broad ligament:four associated with von Hippel-Lindau disease and one aggressivesporadic type. Histopathology. 2012;60:748-757.
31. Nozawa T, Konda R, Ohsawa T, et al. Clear cell papillarycystadenocarcinoma of the epididymis: a case report and immunohistochemistryof markers for renal cell carcinoma. Histol Histopathol.2013;28:321-326.
32. Brady A, Nayar A, Cross P, et al. A detailed immunohistochemicalanalysis of 2 cases of papillary cystadenoma of the broad ligament:an extremely rare neoplasm characteristic of patients with vonHippel-Lindau disease. Int J Gynecol Pathol. 2012;31:133-140.